Research & Development

Mechanical Pressure of the Heartbeat Blocks Cancer Growth
Research & Development Mechanical Pressure of the Heartbeat Blocks Cancer Growth

While cancer aggressively invades almost every organ within the human anatomy, the human heart possesses a unique and formidable resistance that has baffled the scientific community for decades. Despite its constant exposure to the entire blood supply and its high metabolic activity, primary

Can Epigenetic Mapping Help Reverse Type 2 Diabetes?
Research & Development Can Epigenetic Mapping Help Reverse Type 2 Diabetes?

The clinical management of metabolic disorders is undergoing a radical shift as researchers move beyond generic tissue analysis to decode the intricate molecular mechanisms governing individual pancreatic cells. Historically, the medical community viewed type 2 diabetes through the lens of

Disturbed Flow Spurs Purine-Fueled DNA Repair in Arteries
Research & Development Disturbed Flow Spurs Purine-Fueled DNA Repair in Arteries

At the very sites where arteries branch and curve, the blood’s mechanical turbulence quietly erodes endothelial defenses while seeding DNA injury that stokes plaque formation yet, paradoxically, also triggers a built-in metabolic countermeasure. New research led by Baylor College of Medicine and

Can a Single RAD52 Ring Guide BRCA-Selective Cancer Drugs?
Research & Development Can a Single RAD52 Ring Guide BRCA-Selective Cancer Drugs?

Nineteen protein subunits arranged in a near-perfect circle gripped a frayed DNA end, and that spare geometry—simple, symmetric, and relentless—reshaped how a critical cancer target might be stopped. The ring belonged to Mgm101, a yeast mitochondrial homolog of human RAD52, and under a convergence

Can a Stem Cell Injection Heal Chronic Achilles Ruptures?
Research & Development Can a Stem Cell Injection Heal Chronic Achilles Ruptures?

For patients living with a chronic Achilles rupture that has resisted months of therapy and bracing, every step can feel like a wager against pain, weakness, instability, and the fear that a compromised tendon will fail again during even the simplest tasks. Traditional reconstruction can fix the

AP-2 Targets TDP-43 as First Human Trials Begin in Madrid
Research & Development AP-2 Targets TDP-43 as First Human Trials Begin in Madrid

A disease that steals movement while leaving thought intact demanded more than incremental symptom care, and that urgency set the stage for a candidate built to confront the fault line where motor neurons first begin to fail. AP-2, now entering first-in-human testing at La Princesa University

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later